KMO and Alzheimer disease: Interestingly, lower KYNA levels have been observed in AD patients40, and raising KYNA levels via inhibition of kyurinine-3-monooxygenase (KMO; another enzyme that acts on kyurenine) ameliorates neurodegeneration in vivo41.